marginally significantP = 0.059
33.76 ± 2.79 μmol · l −1 · min; P < 0.001), marginally significant in IFG/IGT versus NGT (49.69 ± 4.59 vs. 39.50 ± 2.59; P = 0.059), and similar in metabolic syndrome versus non–metabolic syndrome (47.74 ± 3.66 vs. 40.12 ± 2.78).